November 2020

Zoloft enters list of 10 most commonly prescribed drugs in Australia

An increase in women being diagnosed with depression is partly behind a significant rise in prescriptions of the antidepressant sertraline – sold under the brand name Zoloft – which is in the list of Australia’s most commonly prescribed drugs for the first time. On Tuesday Australian Prescriber published its annual list of the 10 most […]

Zoloft enters list of 10 most commonly prescribed drugs in Australia Read More »

Logistics providers gear up for Covid-19 distribution – Pharmaceutical Commerce

In a few weeks, if all goes well with FDA reviews and approvals, Pfizer’s Covid-19 vaccine will begin to be administered to healthcare workers in the US, followed by Moderna’s. We will immediately begin hearing about, on the one hand, well-connected people of any background getting the vaccine, and on the other hand, people saying

Logistics providers gear up for Covid-19 distribution – Pharmaceutical Commerce Read More »

AstraZeneca staffers targeted in suspected hacking scheme amid work on COVID vaccine: report

After China, Iran and Russia, North Korea is the latest to be fingered for attempting to steal Western research into COVID-19. Its target? AstraZeneca. North Korean hackers used sham recruiting schemes to try to breach AstraZeneca’s systems in recent weeks, Reuters reported, citing two people familiar with the matter. The alleged cyberattacks, which are not thought

AstraZeneca staffers targeted in suspected hacking scheme amid work on COVID vaccine: report Read More »

Revance’s frown-line injection latest to face regulatory delay after FDA can’t hit inspection deadline

As COVID-19 continues to rage around the globe, the FDA’s inspection schedule has fallen into complete shambles—often to the detriment of drugmakers looking to bring new therapies to market. But the delays are hitting the aesthetics business, too, and now another drugmaker has had to hit the pause button.  Revance will have to wait for

Revance’s frown-line injection latest to face regulatory delay after FDA can’t hit inspection deadline Read More »

McKinsey consultants proposed Purdue offer rebates for opioid overdoses: NYT

Purdue Pharma has faced years of intense scrutiny over its opioid painkiller marketing, culminating with last month’s Department of Justice settlement worth more than $8 billion. Behind the scenes, global consulting leader McKinsey & Company helped guide marketing strategy for years and pitched the idea of rebates to distributors for overdoses, according to The New York Times.  After last month’s settlement, new documents released

McKinsey consultants proposed Purdue offer rebates for opioid overdoses: NYT Read More »

London A.I. Lab Claims Breakthrough That Could Accelerate Drug Discovery

Some scientists spend their lives trying to pinpoint the shape of tiny proteins in the human body. Proteins are the microscopic mechanisms that drive the behavior of viruses, bacteria, the human body and all living things. They begin as strings of chemical compounds, before twisting and folding into three-dimensional shapes that define what they can

London A.I. Lab Claims Breakthrough That Could Accelerate Drug Discovery Read More »

Signed, sealed, delivered: Pfizer marks 1st ‘mass air shipment’ of COVID-19 shot amid cold-chain scrutiny

Pfizer, alone among its peers, has faced fever-pitch scrutiny over the stringent cold storage requirements for its COVID-19 vaccine—and the logistical challenges that could pose. Looking to ease the doubters’ concerns, Pfizer has now shipped its first doses by air to the U.S., and distributors are watching closely.  Late last week, United Airlines started ferrying Pfizer’s

Signed, sealed, delivered: Pfizer marks 1st ‘mass air shipment’ of COVID-19 shot amid cold-chain scrutiny Read More »

Boehringer Ingelheim features Queen Latifah, Bernie Williams in new lung disease documentary

Actor and musician Queen Latifah and retired All-Star baseball player Bernie Williams have both lost parents to interstitial lung disease and both already serve as Boehringer Ingelheim spokespeople. And now, the two are helping the company premiere a new documentary about the condition. The TV movie “Beyond Breathless”—which debuts Saturday at noon on the A&E channel—will feature the

Boehringer Ingelheim features Queen Latifah, Bernie Williams in new lung disease documentary Read More »

AbbVie trio of immunology ads joins pharma chorus urging doctor visits during pandemic

Going to the doctor during the COVID-19 pandemic can be complicated. AbbVie is the latest pharma to launch a campaign to remind patients—in this case, patients with autoimmune diseases—that it’s also necessary. Three new AbbVie TV commercials emphasize the importance of continuing care despite the pandemic. Each ad—one each for psoriasis, Crohn’s disease and rheumatoid arthritis—highlights

AbbVie trio of immunology ads joins pharma chorus urging doctor visits during pandemic Read More »

Novavax, swamped with FDA’s manufacturing ‘questions,’ hopes for U.S. coronavirus shot trial within the year

With two players in the race for a COVID-19 vaccine nearing the finish line on world-first regulatory approvals, Maryland biotech Novavax continues to lag behind in getting its candidate into a late-stage trial in the U.S. Now, that trial has been pushed back further as the FDA targets its manufacturing plans. The FDA has lobbed

Novavax, swamped with FDA’s manufacturing ‘questions,’ hopes for U.S. coronavirus shot trial within the year Read More »

Scroll to Top